---
figid: PMC5961736__nihms964503f2
figlink: /pmc/articles/PMC5961736/figure/F2/
number: F2
caption: Illustration of JAK/STAT signaling pathway that inspires effective therapeutic
  targets in lymphoma. JAK/STAT pathway is a key mediator of cytokine signaling in
  both physiological and pathological conditions. Upon binding cytokines, basally
  inactive JAKs engaged to cytokine receptors are phosphorylated and thereby phosphorylate
  STATs. After being dimerization, phosphorylated STATs translocate from cytoplasm
  to nucleus and then bind to specific targeted genes. In turn, this pathway is negatively
  regulated by SOCS and CIS. The inhibitors targeting JAKs, STATs, or ILs are being
  expected to show expected treatment efficacy in some lymphomas. JAK, Janus kinase;
  STAT, signal transducer and activator of transcription; SHP, Src homology region
  2 domain-containing phosphatase; SOCS, suppressor of cytokine signaling; CIS, cytokine-inducible
  SH2-containing protein; PI3K, phosphoinositide-3-kinase; AKT, v-akt murine thymoma
  viral oncogene homolog1; mTOR, mechanistic target of Rapamycin; ERK, extracellular
  signal-regulated kinase; CCND1, cyclin D1; VEGF, vascular endothelial growth factor.
pmcid: PMC5961736
papertitle: Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers
  in Lymphoid Malignancies.
reftext: Ruifang Sun, et al. Crit Rev Oncog. ;22(5-6):527-557.
pmc_ranked_result_index: '71381'
pathway_score: 0.9207635
filename: nihms964503f2.jpg
figtitle: Illustration of JAK/STAT signaling pathway that inspires effective therapeutic
  targets in lymphoma
year: ''
organisms:
- Homo sapiens
ndex: 6c911e15-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5961736__nihms964503f2.html
  '@type': Dataset
  description: Illustration of JAK/STAT signaling pathway that inspires effective
    therapeutic targets in lymphoma. JAK/STAT pathway is a key mediator of cytokine
    signaling in both physiological and pathological conditions. Upon binding cytokines,
    basally inactive JAKs engaged to cytokine receptors are phosphorylated and thereby
    phosphorylate STATs. After being dimerization, phosphorylated STATs translocate
    from cytoplasm to nucleus and then bind to specific targeted genes. In turn, this
    pathway is negatively regulated by SOCS and CIS. The inhibitors targeting JAKs,
    STATs, or ILs are being expected to show expected treatment efficacy in some lymphomas.
    JAK, Janus kinase; STAT, signal transducer and activator of transcription; SHP,
    Src homology region 2 domain-containing phosphatase; SOCS, suppressor of cytokine
    signaling; CIS, cytokine-inducible SH2-containing protein; PI3K, phosphoinositide-3-kinase;
    AKT, v-akt murine thymoma viral oncogene homolog1; mTOR, mechanistic target of
    Rapamycin; ERK, extracellular signal-regulated kinase; CCND1, cyclin D1; VEGF,
    vascular endothelial growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND1
  - MYC
  - VEGFD
  - VEGFA
  - AKT2
  - PIK3R3
  - VEGFB
  - PGF
  - CISH
  - PIK3CB
  - PIK3CA
  - NRAS
  - PTPN6
  - MAPK3
  - SRC
  - VEGFC
  - PTPN11
  - PIK3R5
  - PIK3R6
  - MAPK1
  - BCL2
  - MAP2K2
  - HRAS
  - AKT3
  - AKT1
  - PIK3CG
  - STAT3
  - STAT1
  - ARAF
  - PIK3R4
  - RAF1
  - KRAS
  - MTOR
  - MAP2K1
  - BRAF
  - STAT4
  - STAT5A
  - PIK3CD
  - STAT6
  - STAT2
  - STAT5B
  - Tofacitinib
  - Ruxolitinib
  - Momelotinib
  - Pacritinib
  - Pyrimethamine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: CIS
  symbol: CIS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SHP1
  symbol: SHP-1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: ErK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: socs
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ErK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: BCL2,MYC,CCND1,VEGF,etc.
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
chemicals:
- word: Tofacitinib
  source: MESH
  identifier: C479163
- word: Ruxolitinib
  source: MESH
  identifier: C540383
- word: Momelotinib
  source: MESH
  identifier: C546012
- word: Pacritinib
  source: MESH
  identifier: C561234
- word: Pyrimethamine
  source: MESH
  identifier: D011739
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5961736__F2
redirect_from: /figures/PMC5961736__F2
figtype: Figure
---
